NeoReviews Vol.9 No.1 2008 e42
© 2008 American Academy of Pediatrics
Strip of the Month
January 2008
Maurice L. Druzin, MD*
Julie M.R. Arafeh, RN, MSN
* Charles B. and Ann L. Johnson Professor of Obstetrics; Chief, Division of Maternal-Fetal Medicine; Co-Medical Director, Mid-Coastal California Perinatal Outreach Program, Stanford University School of Medicine, Palo Alto, Calif
Coordinator of Perinatal Outreach, Mid-Coastal California Perinatal Outreach Program, Stanford University, Palo Alto, Calif
 |
Electronic Fetal Monitoring Case Review Series
|
|---|
Electronic fetal monitoring (EFM) is a popular technology used to establish fetal well-being. Despite its widespread use, terminology used to describe patterns seen on the monitor has not been consistent until recently. In 1997, the National Institute of Child Health and Human Development (NICHD) Research Planning Workshop published guidelines for interpretation of fetal tracings. This publication was the culmination of 2 years of work by a panel of experts in the field of fetal monitoring and has been endorsed by both the American College of Obstetricians and Gynecologists (ACOG) and the Association of Womens Health, Obstetric and Neonatal Nurses (AWHONN). The terminology definitions and assumptions found in the NICHD publication form the basis for interpretation of the fetal tracings in this series and are summarized here. Normal values for arterial umbilical cord gas values and indications of acidosis are defined in the Table .
Table 1. Arterial Umbilical Cord Gas Values
|
pH |
Pco2 (mm Hg) |
Po2 (mm Hg) |
Base Excess |
|
| Normal* |
7.20 (7.15 to 7.38) |
<60 (35 to 70) |
20 |
–10 (–2.0 to –9.0) |
| Respiratory Acidosis |
<7.20 |
>60 |
Variable |
–10 |
| Metabolic Acidosis |
<7.20 |
<60 |
Variable |
–10 |
| Mixed Acidosis |
<7.20 |
>60 |
Variable |
–10 |
|
* Normal ranges from Obstet Gynecol Clin North Am. 1999;26:695
Table 2. Arterial Umbilical Cord Gas Values
|
pH |
Pco2 (mm Hg) |
Po2 (mm Hg) |
Base Excess |
|
| Normal* |
7.20 (7.15 to 7.38) |
<60 (35 to 70) |
20 |
–10 (–2.0 to –9.0) |
| Respiratory Acidosis |
<7.20 |
>60 |
Variable |
–10 |
| Metabolic Acidosis |
<7.20 |
<60 |
Variable |
–10 |
| Mixed Acidosis |
<7.20 |
>60 |
Variable |
–10 |
| Patient |
7.17 |
66 |
6 |
–6 |
|
* Normal ranges from Obstet Gynecol Clin North Am. 1999;26:695
Assumptions from the NICHD Workshop
- Definitions are developed for visual interpretation
- Definitions apply to tracings generated by internal or external monitoring devices
- Periodic patterns are differentiated based on waveform, abrupt or gradual (eg, late decelerations have a gradual onset and variable decelerations have an abrupt onset)
- Long- and short-term variability are evaluated visually as a unit
- Gestational age of the fetus is considered when evaluating patterns
- Components of fetal heart rate (FHR) do not occur alone and generally evolve over time
Definitions
Baseline Fetal Heart Rate
- Approximate mean FHR rounded to increments of 5 beats/min in a 10-minute segment of tracing, excluding periodic or episodic changes, periods of marked variability, and segments of baseline that differ by >25 beats/min
- In the 10-minute segment, the minimum baseline duration must be at least 2 minutes or the baseline for that segment is indeterminate
- Bradycardia is a baseline of <110 beats/min; tachycardia is a baseline of >160 beats/min
- Sinusoidal baseline has a smooth sine wave-like pattern, with waves having regular frequency and amplitude
Baseline Variability
- Fluctuations in the baseline FHR of two cycles per minute or greater, fluctuations are irregular in amplitude and frequency, fluctuations are visually quantitated as the amplitude of the peak to trough in beats per minute
- Classification of variability:
Absent: Amplitude range is undetectable
Minimal: Amplitude range is greater than undetectable to 5 beats/min
Moderate: Amplitude range is 6 to 25 beats/min
Marked: Amplitude range is >25 beats/min
Accelerations
- Abrupt increase in FHR above the most recently determined baseline
- Onset to peak of acceleration is <30 seconds, acme is
15 beats/min above the most recently determined baseline and lasts
15 seconds but <2 minutes
- Before 32 weeks gestation, accelerations are defined by an acme
10 beats/min above the most recently determined baseline for
10 seconds
- Prolonged acceleration lasts
2 minutes but <10 minutes
Late Decelerations
- Gradual decrease in FHR (onset to nadir
30 seconds) below the most recently determined baseline, with nadir occurring after the peak of uterine contractions
- Considered a periodic pattern because it occurs with uterine contractions
Early Decelerations
- Gradual decrease in FHR (onset to nadir
30 seconds) below the most recently determined baseline, with nadir occurring coincident with uterine contraction
- Also considered a periodic pattern
Variable Decelerations
- Abrupt decrease in FHR (onset to nadir <30 seconds)
- Decrease is
15 beats/min below the most recently determined baseline lasting
15 seconds but <2 minutes
- May be episodic (occurs without a contraction) or periodic
Prolonged Decelerations
- Decrease in the FHR
15 beats/min below the most recently determined baseline lasting
2 minutes but <10 minutes from onset to return to baseline
- Decelerations are tentatively called recurrent if they occur with
50% of uterine contractions in a 20-minute period.
- We encourage readers to examine each strip in the case presentation and make a personal interpretation of the findings before advancing to the expert interpretation provided.
 |
Case Presentation
|
|---|
History
A 19-year-old G1P0 woman is admitted to labor and delivery for induction at 38 weeks gestation because of preeclampsia. Past medical and social histories are unremarkable, and the pregnancy was uncomplicated until 36 weeks gestation, when urine dipstick measurement for protein was 3+, and the womans blood pressure was 100/60 mm Hg. A 24-hour urine collection for protein measured 385 mg. She was followed closely as an outpatient, and at 38 weeks gestation, her blood pressure was 129/91 mm Hg and repeat 24-hour urine collection documented increased protein to 847 mg. Other laboratory findings were normal. Upon admission to labor and delivery, the womans blood pressure is 127/91 mm Hg, and she reports headache and visual changes. Vaginal examination shows the cervix to be a fingertip dilated, thick, and high. Misoprostol is administered vaginally to ripen the cervix to facilitate induction of labor, and an initial fetal tracing is obtained (Fig. 1).
Findings on EFM Strip #1 are: - Variability: Moderate
- Baseline Rate: 145 beats/minute
- Episodic Pattern: Accelerations
- Periodic Pattern: None
- Uterine Contractions: None
- Interpretation: Reassuring fetal heart rate tracing based on the presence of moderate variability and accelerations
- Differential Diagnosis: Despite the diagnosis of preeclampsia, the fetus has a reassuring tracing indicating adequate fetal oxygenation and an intact central nervous system
- Action: None needed; continue to observe tracing and fetal response to labor
Progression of Labor
Approximately 2 hours later, the patient begins to feel contractions and another tracing is obtained (Fig. 2).
Findings on EFM Strip #2 are: - Variability: Minimal
- Baseline Rate: 140 beats/min
- Episodic Pattern: None
- Periodic Pattern: None
- Uterine Contractions: None noted on the tracing, although the patient reports beginning to feel contractions
- Interpretation: Variability has decreased in the tracing, and the patient reports feeling less fetal movement; the reassuring sign is the continuing normal baseline rate on a tracing that previously exhibited moderate variability with the absence of decelerations.
- Differential Diagnosis: Initial signs of fetal stress or a period of fetal sleep, both of which may present similarly
- Action: Continue to observe the tracing. Most fetal sleep cycles are short, and variability will return after the sleep cycle finishes. If the time period is extended or the clinician detects other signs of concern, a vibroacoustic stimulator can be used to arouse the fetus and elicit an acceleration of the fetal heart rate. However, the lack of an acceleration after use of a vibroacoustic stimulator does not necessarily indicate fetal compromise. If concern for fetal status remains, the mother and fetus should be evaluated further, including evaluation of maternal status and close observation of the fetal heart rate for further signs of deterioration. Plans to intervene on behalf of the fetus may be discussed with other staff and the parents.
Within 20 minutes, the tracing improves (Fig. 3).
Findings on EFM Strip #3 are: - Variability: Moderate
- Baseline Rate: 145 beats/min
- Episodic Pattern: Accelerations
- Periodic Pattern: None
- Uterine Contractions: None noted, although patient reports feeling contractions
- Interpretation: Reassuring tracing, uterine contractions not tracing
- Differential Diagnosis: Fetal sleep cycle
- Action: Adjust tocodynamometer to detect uterine contractions. If unable to detect contractions with the external tocodynamometer, an intrauterine pressure catheter may need to be inserted. The cervix needs to be dilated to approximately 3 to 4 cm to allow passage of the catheter, and the membranes need to be ruptured.
Approximately 6 hours later, the patient is 6 cm dilated and is requesting an epidural. A fetal tracing (Fig. 4) is obtained as epidural placement is completed.
Findings on EFM Strip #4 are: - Variability: Moderate
- Baseline rate: 140 beats/min
- Episodic Pattern: None
- Periodic Pattern: None
- Uterine Contractions: Every 2 to 3 minutes, lasting approximately 60 seconds; resting tone and intensity per palpation
- Interpretation: Reassuring tracing. The early section of EFM Strip #4 is a maternal tracing while the woman is sitting for an epidural. The maternal tracing is confirmed by the question mark symbols at the top of the tracing, which are produced when the fetal monitor detects two signals that match. In this case, the maternal pulse oximeter and the signal from the fetal tracing were the same.
- Differential Diagnosis: Reassuring tracing
- Action: Adjust the ultrasound transducer to pick up the fetal tracing
Oxytocin therapy is started to augment uterine contractions after epidural placement. A fetal tracing (Fig. 5) is obtained approximately 1.5 hours later.
Findings on EFM Strip #5 are: - Variability: Moderate
- Baseline rate: 150 beats/min
- Episodic Pattern: None
- Periodic Pattern: Variable decelerations
- Uterine Contractions: Every 1.5 minutes, lasting 50 seconds; resting tone and intensity of contractions per palpation
- Interpretation: Reassuring fetal tracing with concerning features, variable decelerations
- Differential Diagnosis: Fetal compromise due to cord compression or uterine hyperstimulation
- Action: Change patient position to attempt to relieve pressure on the umbilical cord. Decrease or discontinue oxytocin administration until 60 seconds of uterine relaxation is seen between contractions. Vaginal examination can be performed to rule out prolapse of the umbilical cord. If these actions are not successful, the tracing should be evaluated further to determine if immediate action is needed to deliver the fetus.
The previously noted actions are taken without resolution of the decelerations, and the decision is made to deliver the fetus by emergent cesarean section. The patient is taken to the operating suite in an urgent but controlled fashion. A fetal tracing (Fig. 6) is obtained in the operating suite.
Findings on EFM Strip #6 are: - Variability: Moderate
- Baseline rate: 165 beats/min
- Episodic Pattern: Variable decelerations
- Periodic Pattern: Unable to determine
- Uterine Contractions: Not recorded
- Interpretation: Reassuring fetal tracing with unresolved variable decelerations
- Differential Diagnosis: Variable decelerations are attributed to cord compression
- Action: Proceed with delivery
Outcome
A viable female infant weighing 2,543 g and having Apgar scores of 8 and 9 at 1 and 5 minutes, respectively, is delivered. She is taken in stable condition to the nursery for observation during maternal recovery. Both mother and infant do well.
 |
Footnotes
|
|---|
Author Disclosure
Dr Druzin and Ms Arafeh did not disclose any financial relationships relevant to this article.

CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?